SREBF1 and metabolic dysfunction-associated steatotic liver disease: In NAFLD-induced liver injury, ACN attenuated oxidative stress and inflammation by three independent mechanisms: inhibition of lipogenesis by reducing sterol regulatory element binding protein-1c (SREBP-1c), promotion of lipolysis by induction of PPARα activity, and reduction of oxidative stress (Valenti et al., 2013).